MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 358 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $705,000 | +72.0% | 11,695 | +31.2% | 0.01% | +66.7% |
| Q1 2016 | $410,000 | +113.5% | 8,915 | +123.9% | 0.00% | +200.0% |
| Q4 2015 | $192,000 | -46.4% | 3,982 | -52.7% | 0.00% | -66.7% |
| Q3 2015 | $358,000 | +3.8% | 8,417 | +178.6% | 0.00% | 0.0% |
| Q2 2015 | $345,000 | +13.5% | 3,021 | +28.4% | 0.00% | +50.0% |
| Q1 2015 | $304,000 | +31.0% | 2,352 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $232,000 | -12.8% | 2,326 | -13.4% | 0.00% | 0.0% |
| Q3 2014 | $266,000 | +25.5% | 2,687 | -2.4% | 0.00% | 0.0% |
| Q2 2014 | $212,000 | +1.4% | 2,754 | -15.0% | 0.00% | 0.0% |
| Q1 2014 | $209,000 | +16.8% | 3,241 | +15.5% | 0.00% | 0.0% |
| Q4 2013 | $179,000 | -68.5% | 2,807 | -70.4% | 0.00% | -60.0% |
| Q3 2013 | $568,000 | +126.3% | 9,482 | +86.2% | 0.01% | +150.0% |
| Q2 2013 | $251,000 | – | 5,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |